A gap analysis of the United States death care sector to determine training and education needs pertaining to highly infectious disease mitigation and management

Journal of Occupational and Environmental Hygiene

Volumn 14, Issue 9, 2017, Pages 674-680

  Le, Aurora B ^a   Witter, Lesley ^b   Herstein, Jocelyn J ^c   Jelden, Katelyn C ^d   Beam, Elizabeth L ^e,f   Gibbs, Shawn G ^a   Lowe, John J ^c,e  

^a INDIANA UNIVERSITY   (United States)

^b Directors Association (NFDA)   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e Nebraska Medicine   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Death care; Ebola virus disease; Highly infectious remains; Infectious disease education; Infectious disease training

Indexed keywords

ADULT; AGED; ARTICLE; BODY REMAINS; COMFORT; EMPLOYEE; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; INFECTION; MALE; MEDICAL EDUCATION; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; PERCEPTION; POLICY; POSTHUMOUS CARE; UNITED STATES; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION; WORKER; COMMUNICABLE DISEASE; COMMUNICABLE DISEASE CONTROL; CREMATION; EDUCATION; FUNERAL HOME; PROCEDURES; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; CREMATION; FUNERAL HOMES; HEMORRHAGIC FEVERS, VIRAL; HUMANS; MORTUARY PRACTICE; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 85044674287     PISSN: 15459624     EISSN: 15459632     Source Type: Journal    
DOI: 10.1080/15459624.2017.1319570     Document Type: Article

References (25)

1. Haverkort, J.M., A.B. Minderhoud, J.D. Wind, L.P. Leenen, A.I. Hoepelman, and P.M. Ellerbroek: Hospital preparations for viral hemorrhagic fever patients and experience gained from admission of an Ebola patient. Emerg. Infectious Dis. 22:184–191 (2016).
2. Jelden, K.C., P.C. Iwen, J.J. Herstein, P.D. Biddinger, C.S. Kraft, L. Saiman, et al.: US Ebola Treatment Center clinical laboratory support. J. Clin. Microbiol. 54:1031– 1035 (2016).
3. Lowe, J.J., P.L. Olinger, S.G. Gibbs, K. Rengarajan, E.L. Beam, K.C. Boulter, et al.: Environmental infection control considerations for Ebola. Am. J. Infect. Control. 43:747–749 (2015).
4. Lyon, G.M., A.K. Mehta, J.B. Varkey, K. Brantly, L. Plyler, A.K. McElroy, et al.: Clinical care of two patients with Ebola virus disease in the United States. New Eng. J. Med. 371:2402–2409 (2014).
5. Lowe J.J., S.G. Gibbs, S.S. Schwedhelm, J. Nguyen, P.W. Smith: Nebraska Biocontainment Unit perspective on disposal of Ebola medical waste. Am. J. Infect. Control 30:1–2 (2014).
6. Schwedhelm, S., E.L. Beam, R.D. Morris, and J.G. Sebastian: Reflections on interprofessional team-based clinical care in the ebola epidemic: The Nebraska Medicine experience. Nurs. Outlook. 63:27–29 (2015).
7. Smith, P.W., K.C. Boulter, A.L. Hewlett, C.J. Kratochvil, E.J. Beam, S.G. Gibbs, et al.: Planning and response to Ebola virus disease: an integrated approach. Am. J. Infect. Control. 43:441–446 (2015).
8. Wadman, M.C., S.S. Schwedhelm, S. Watson, J. Swanhorst, S.G. Gibbs, J.J. Lowe, et al.: Emergency Department Processes for the Evaluation and Management of Persons Under Investigation for Ebola Virus Disease. Ann. Emerg. Med. 66:306–314 (2015).
9. Otter, J.A., S. Mepham, B. Athan, D. Mack, R. Smith, M. Jacobs, et al.: Terminal decontamination of the Royal Free London’s high-level isolation unit after a case of Ebola virus disease using hydrogen peroxide vapor. Am. J. Infect. Control. 44:233–235 (2016).
10. Hewlett, A.L., J.B. Varkey, P.W. Smith, and B.S. Ribner: Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units. Curr. Opin. Infect. Dis. 28:343–348 (2015).
11. Uyeki, T.M., A.K. Mehta, R.T. Davey Jr, A.M. Liddell, T. Wolf, P. Vetter, et al.: Clinical management of Ebola virus disease in the United States and Europe. New Eng. J. Med. 374:636–646 (2016).
12. Iwen, P.C., P.W. Smith, A.L. Hewlett, C.J. Kratochvil, S.J. Lisco, J.N. Sullivan, et al.: Safety considerations in the laboratory testing of specimens suspected or known to contain Ebola virus. Am. J. Clin. Pathol. 143:4–5 (2015).
13. Beam, E.L., S. Schwedhelm, K. Boulter, C. Kratochvil, J. Lowe, A. Hewlett, et al.: Personal protective equipment processes and rationale for the Nebraska Biocontainment Unit during the 2014 activations for Ebola virus disease. Am. J. Infect. Control. 44:340–342 (2016).
14. Centers for Disease Control and Prevention: “Interim Guidance for U.S. Hospital Preparedness for Patients Under Investigation (PUIs) or with Confirmed Ebola Virus Disease (EVD): A Framework for a Tiered Approach.” Available at http://www.cdc.gov/vhf/ebola/healthcare-us/preparing/hospitals.html (accessed October 3, 2015).
15. National Institute of Environmental Health Sciences: “Ebola Biosafety and Infectious Disease Response Training program.” Available at https://www.niehs.nih.gov/careers/hazmat/about_wetp/ebola/index.cfm (accessed October 16, 2016).
16. DiGiovanni, C., J. Conley, D. Chiu, and J. Zaborski: Factors influencing compliance with quarantine in Toronto during the 2003 SARS outbreak. Biosecur. Bioterror. 2:265–272 (2004).
17. Santora, M.: “Doctor in New York City Is Sick With Ebola.” New York Times, October 24, 2014. Available at http://www.nytimes.com/2014/10/24/nyregion/craig-spe ncer-is-tested-for-ebola-virus-at-bellevue-hospital-in-new-york-city.html (accessed October 10, 2016).
18. Gershon, R.R., L.A. Magda, H.E. Riley, and J.A. Merrill: Mass fatality preparedness in the death care sector. J. Occup. Environ. Med. 53:1179–1186 (2011).
19. Gershon, R.R., M.G. Orr, Q. Zhi, J.A. Merrill, D.Y. Chen, H.E. Riley, et al.: Mass fatality preparedness among medical examiners/coroners in the United States: A cross-sectional study. BMC Public Health. 14:1–15 (2014).
20. Fusco, F., V. Puro, A. Baka, B. Bannister, H.-R. Brodt, P. Brouqui, et al.: Isolation rooms for highly infectious diseases: An inventory of capabilities in European countries. J. Hosp. Infect. 73:15–23 (2009).
21. World Health Organization: “Lassa Fever – Germany.” Available at http://www.who.int/csr/don/23-march-2016-lassa-fever-germany/en/(accessed March 23, 2016).
22. Heymann, D.: Control of Communicable Diseases Manual, 20th Edition. Washington, DC: APHA Press, 2014.
23. Wolf, T.: “Update on recent imported case of Lassa fever with secondary transmission in Germany.” Oral presentation at World Health Organization Viral Hemorraghic Fever Workshop. Berlin, Germany, April 4–6, 2016.
24. Fusco, F., S. Schilling, V. Puro, H.R. Brodt, P. Follin, B. Jarhall, et al.: EuroNHID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase of a European survey. Clin. Microbiol. Infec. 15:711–719 (2009).
25. United States Department of Health and Human Services: “Regional Offices.” Available at http://www.hhs. gov/about/agencies/regional-offices/(accessed October 16, 2016).